Mauree Whitaker
Family · Bishop, GANPI 1619262946
Payments from drug & device makers
Across 261 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$642
- Supernus Pharmaceuticals, Inc.$608
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$571
- Takeda Pharmaceuticals U.S.A., Inc.$446
- Johnson & Johnson$416
- Otsuka America Pharmaceutical, Inc.$394
- plus $2K from 15 others
What the payments were for
- Speaking & faculty fees$150%
- Food & beverage$4,89098%
- Education$671%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $642 |
| Supernus Pharmaceuticals, Inc. | 27 | $608 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $571 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $446 |
| Johnson & Johnson | 15 | $416 |
| Otsuka America Pharmaceutical, Inc. | 18 | $394 |
| Neurocrine Biosciences, Inc. | 11 | $265 |
| Alkermes, Inc. | 12 | $255 |
| Teva Pharmaceuticals USA, Inc. | 17 | $224 |
| Vanda Pharmaceuticals Inc. | 8 | $200 |
| Lundbeck LLC | 9 | $198 |
| Axsome Therapeutics, Inc. | 9 | $186 |
| Bayer | 1 | $120 |
| E.r. Squibb & Sons, L.L.C. | 5 | $99 |
| Tris Pharma Inc | 5 | $81 |
| Corium, LLC | 6 | $73 |
| Xeris Pharmaceuticals, Inc. | 1 | $61 |
| Indivior Inc. | 3 | $52 |
| Noven Therapeutics, LLC | 2 | $42 |
| Tempus AI, Inc | 1 | $23 |
| Mckesson Medical-surgical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,972 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 19 | $29,402 |
| CaplytaLumateperone Tosylate | 15 | $27,045 |
| TrintellixVortioxetine Hydrobromide | 20 | $10,428 |
| Paliperidone ErPaliperidone | 13 | $2,370 |
| Doxepin Hcl | 13 | $791 |
| Duloxetine Hcl | 38 | $536 |
| Hydroxyzine Hcl | 32 | $510 |
| Divalproex Sodium | 13 | $371 |
| Haloperidol Decanoate | 11 | $349 |
| Aripiprazole | 22 | $291 |
| Buspirone Hcl | 26 | $283 |
| Olanzapine | 13 | $235 |
| Gabapentin | 18 | $180 |
| Clonazepam | 30 | $112 |
| Bupropion XlBupropion Hcl | 13 | $104 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $642 | $29,40219 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $571 | $27,04515 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $446 | $10,42820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Bishop
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.